AUB ScholarWorks

International adaptation and use of NCCN guidelines

Show simple item record

dc.contributor.author Bazarbachi A.
dc.contributor.author Zelenetz A.D.
dc.contributor.editor
dc.date 2014
dc.date.accessioned 2017-10-05T15:38:48Z
dc.date.available 2017-10-05T15:38:48Z
dc.date.issued 2014
dc.identifier
dc.identifier.isbn
dc.identifier.issn 15401405
dc.identifier.uri http://hdl.handle.net/10938/16525
dc.description.abstract The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) describe a continuum of cancer care in the United States, from initial diagnosis through treatment and referral to hospice beyond treatment. However, in many other countries, there are no regional or national clinical practice guidelines. In 2008, the NCCN-MENA (Middle East and North Africa) project was launched to adapt the NCCN Guidelines to this part of the world. During their joint presentation at the NCCN 19th Annual Conference, Dr. Ali Bazarbachi and Dr. Andrew D. Zelenetz explored the modification process of NCCN Guidelines for MENA and shared examples of how it improved the care of patients with adult T-cell leukemia or lymphoma and younger patients with diffuse large B-cell lymphoma-regardless of where they live. © JNCCN - Journal of the National Comprehensive Cancer Network.
dc.format.extent
dc.format.extent Pages: (838-841)
dc.language English
dc.publisher Harborside Press;
dc.relation.ispartof Publication Name: JNCCN Journal of the National Comprehensive Cancer Network; Publication Year: 2014; Volume: 12; Pages: (838-841);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title International adaptation and use of NCCN guidelines
dc.type Conference Paper
dc.contributor.affiliation Bazarbachi, A., Department of Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Zelenetz, A.D., Weill Medical College of Cornell University, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 330, New York, NY 10065, United States
dc.contributor.authorAddress Bazarbachi, A.; Department of Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon; email: bazarbac@aub.edu.lb
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision
dc.contributor.authorEmail
dc.contributor.faculty Faculty of Medicine
dc.contributor.authorInitials
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited
dc.description.citedCount
dc.description.citedTotWOSCount
dc.description.citedWOSCount
dc.format.extentCount 4
dc.identifier.articleNo
dc.identifier.coden
dc.identifier.pubmedID
dc.identifier.scopusID 84902465579
dc.identifier.url
dc.publisher.address
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr
dc.relation.ispartOfIssue
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle JNCCN Journal of the National Comprehensive Cancer Network
dc.relation.ispartofPubTitleAbbr JNCCN J. Nat. Compr. Cancer Netw.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 12
dc.source.ID
dc.type.publication Series
dc.subject.otherAuthKeyword
dc.subject.otherChemCAS bleomycin, 11056-06-7, 9041-93-4
dc.subject.otherChemCAS carboplatin, 41575-94-4
dc.subject.otherChemCAS cyclophosphamide, 50-18-0
dc.subject.otherChemCAS cytarabine, 147-94-4, 69-74-9
dc.subject.otherChemCAS doxorubicin, 23214-92-8, 25316-40-9
dc.subject.otherChemCAS etoposide, 33419-42-0
dc.subject.otherChemCAS ifosfamide, 3778-73-2
dc.subject.otherChemCAS methotrexate, 15475-56-6, 59-05-2, 7413-34-5
dc.subject.otherChemCAS prednisone, 53-03-2
dc.subject.otherChemCAS rituximab, 174722-31-7
dc.subject.otherChemCAS vincristine, 57-22-7
dc.subject.otherChemCAS vindesine, 53643-48-4
dc.subject.otherChemCAS zidovudine, 30516-87-1
dc.subject.otherIndex alpha interferon
dc.subject.otherIndex bleomycin
dc.subject.otherIndex carboplatin
dc.subject.otherIndex cyclophosphamide
dc.subject.otherIndex cytarabine
dc.subject.otherIndex doxorubicin
dc.subject.otherIndex etoposide
dc.subject.otherIndex ifosfamide
dc.subject.otherIndex methotrexate
dc.subject.otherIndex prednisone
dc.subject.otherIndex rituximab
dc.subject.otherIndex vincristine
dc.subject.otherIndex vindesine
dc.subject.otherIndex zidovudine
dc.subject.otherIndex cancer combination chemotherapy
dc.subject.otherIndex clinical practice
dc.subject.otherIndex conference paper
dc.subject.otherIndex human
dc.subject.otherIndex international cooperation
dc.subject.otherIndex large cell lymphoma
dc.subject.otherIndex Middle East
dc.subject.otherIndex North Africa
dc.subject.otherIndex oncology
dc.subject.otherIndex patient care
dc.subject.otherIndex practice guideline
dc.subject.otherIndex T cell leukemia
dc.subject.otherIndex United Nations
dc.subject.otherIndex United States
dc.subject.otherKeywordPlus
dc.subject.otherWOS


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account